View Older Stories View More Recent Stories

May 14, 2020 08:15AM CareDx and Veracyte Announce Exclusive Partnership for Transplant Rejection Testing on nCounter System
May 7, 2020 04:05PM Veracyte to Present at the UBS Virtual Global Healthcare Conference
May 6, 2020 04:05PM Veracyte Announces First Quarter 2020 Financial Results
May 1, 2020 08:15AM Veracyte Launches “More About You” Campaign to Educate Patients About Thyroid Cancer Diagnosis
Apr 23, 2020 08:15AM CORRECTING and REPLACING Veracyte and Yale Announce Exclusive License to Advance First Genomic Monitoring Test for Idiopathic Pulmonary Fibrosis
Apr 23, 2020 08:15AM Veracyte and Yale Announce Exclusive License to Advance First Genomic Monitoring Test for Idiopathic Pulmonary Fibrosis
Apr 16, 2020 04:32PM Veracyte (VCYT) Announces Prelim. Q1 Results, Withdraws 2020 Financial Guidance
Apr 16, 2020 04:30PM Veracyte Announces Preliminary First Quarter 2020 Financial Results and Provides Business Update in Response to COVID-19 Pandemic
Apr 7, 2020 08:15AM Veracyte Names Tracy Morris as Vice President of Corporate Communications and Investor Relations
Apr 1, 2020 08:15AM Veracyte Announces Novel Gene Fusion Detection with the Afirma Xpression Atlas, Which May Inform Targeted Treatment Decisions for Thyroid Cancer Patients
Mar 2, 2020 11:00AM Veracyte Announces Publication of Nearly 700-Patient Study Using Prosigna Breast Cancer Test to Identify Patients Likely to Benefit from Aggressive Chemotherapy
Feb 25, 2020 04:05PM Veracyte Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides 2020 Financial Outlook
Feb 13, 2020 08:15AM Veracyte to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Feb 6, 2020 01:30PM Veracyte to Release Fourth Quarter and Full-Year 2019 Financial Results on February 25, 2020
Jan 8, 2020 08:15AM Veracyte Announces Biopharmaceutical Collaboration with Acerta Pharma
Dec 3, 2019 05:02PM Veracyte (VCYT) Acquires Exclusive License to NanoString (NSTG) Diagnostics Platform
Dec 3, 2019 05:00PM Veracyte Acquires Exclusive License to NanoString Diagnostics Platform, Positioning Veracyte To Expand Its Genomic Testing Business Globally
Nov 2, 2019 09:30AM Veracyte Announces New Data That Advance Understanding of Genomic Alterations Targeted by Precision Medicine Therapies for Thyroid Cancer
Oct 30, 2019 08:18AM Veracyte (VCYT) Announces New Data Characterizing Genomic Alterations in Thyroid Cancer To Be Presented at ATA
Oct 30, 2019 08:15AM Veracyte Announces New Data Characterizing Genomic Alterations in Thyroid Cancer To Be Presented at 89th Annual Meeting of the American Thyroid Association
Oct 22, 2019 04:15PM Veracyte Announces Third Quarter 2019 Financial Results and Business Progress
Oct 22, 2019 07:08AM Veracyte (VCYT) Announces New Clinical Data Showing First-Ever Noninvasive Nasal Swab Test Can Enable Early Lung Cancer Detection and Diagnosis
Oct 22, 2019 07:00AM Veracyte Announces New Clinical Data Showing First-Ever Noninvasive Nasal Swab Test Can Enable Early Lung Cancer Detection and Diagnosis
Oct 21, 2019 04:15PM Veracyte Announces Clinical Data Demonstrating Clinical Validity and Utility of Percepta Classifier in Lung Cancer Diagnosis When Bronchoscopy Results Are Inconclusive
Oct 21, 2019 09:58AM Veracyte (VCYT) Announces New Data Showing Envisia Genomic Classifier Improves IPF Diagnosis
Oct 21, 2019 09:57AM Veracyte Announces New Data Demonstrating That Envisia Genomic Classifier Improves IPF Diagnosis
Oct 8, 2019 04:30PM Veracyte to Release Third Quarter 2019 Financial Results and Business Progress on October 22, 2019
Oct 7, 2019 08:03AM Veracyte (VCYT) to Announce New Clinical Data for First Noninvasive Nasal Swab Test to Target Early Lung Cancer Detection at CHEST
Oct 7, 2019 08:00AM Veracyte to Announce New Clinical Data for First Noninvasive Nasal Swab Test to Target Early Lung Cancer Detection at CHEST Annual Meeting 2019
Sep 11, 2019 11:04AM Veracyte Announces Publication of Clinical and Analytical Validation Data for Afirma Xpression Atlas
Sep 3, 2019 08:16AM Veracyte (VCYT) Reports Publication of New Study Characterizing Gene Alterations in Thyroid Cancer
Sep 3, 2019 08:15AM Veracyte Announces Publication of New Study Characterizing Gene Alterations in Thyroid Cancer
Aug 28, 2019 04:15PM Veracyte to Present at Upcoming Investor Conferences
Jul 30, 2019 04:15PM Veracyte Announces Second Quarter 2019 Financial Results
Jul 1, 2019 08:00AM Veracyte Names Keith Kennedy Chief Operating Officer and Chief Financial Officer
Jun 27, 2019 04:15PM Veracyte to Release Second Quarter 2019 Financial Results on July 30, 2019
Jun 26, 2019 04:15PM Veracyte Announces Next-Generation Percepta Genomic Sequencing Classifier Now Available to Physicians for Improved Lung Cancer Diagnosis
Jun 24, 2019 08:30AM Veracyte Named a San Francisco Bay Area “Top Workplace” For Sixth Consecutive Year
Jun 17, 2019 08:34AM Veracyte (VCYT) Reports Publication of Data Detailing Clinical Utility of RNA Sequencing-Based Testing
Jun 17, 2019 08:30AM Veracyte Announces New Article Published in Cancer Cytopathology Detailing Clinical Utility of Its RNA Sequencing-Based Testing for Thyroid Cancer Diagnosis and Treatment
Jun 10, 2019 04:15PM Veracyte Announces New Publication of Data Demonstrating Real-World Performance of the Afirma GSC in Thyroid Cancer Diagnosis
Jun 1, 2019 02:15PM Veracyte Announces New Data Showing Potential of Afirma Genomic Test to Guide Targeted Treatment for Medullary Thyroid Cancer Concurrent with Diagnosis
May 29, 2019 04:20PM Veracyte Announces Participation in Two Upcoming Investor Conferences
May 23, 2019 08:00AM Veracyte Announces New Data Demonstrating Afirma Xpression Atlas’s Potential to Inform Treatment Selection for Patients with Medullary Thyroid Cancer to Be Presented at 2019 ASCO Annual Meeting
May 20, 2019 08:08AM Veracyte (VCYT) Unveils Next-Generation Percepta Genomic Sequencing Classifier for Improved Lung Cancer Diagnosis
May 20, 2019 08:00AM Veracyte Unveils Next-Generation Percepta Genomic Sequencing Classifier for Improved Lung Cancer Diagnosis
May 14, 2019 08:30AM Veracyte Names Sangeeta Bhorade, M.D., Medical Director of Pulmonology
May 9, 2019 04:20PM Veracyte to Present at the UBS Global Healthcare Conference
Apr 30, 2019 04:15PM Veracyte Announces First Quarter 2019 Financial Results
Apr 22, 2019 04:17PM Veracyte (VCYT) Receives Regulatory Authorization to Offer Envisia Genomic Classifier for Patients in New York State
View More Recent Stories View Older Stories